Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense [Phase 2]
Phase II trial of subcutaneous immunotherapy for patients with allergic rhinoconjunctivitis due to Phleum pratense has completed; results po…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR [Phase 2]
Phase 2 trial evaluating the efficacy, safety, and pharmacokinetics of bilastine 10 mg or 20 mg given once or twice daily versus placebo for…
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Molekule for Allergic Rhinitis/Asthma [NA]
A Molekule-sponsored clinical trial for asthma and allergic rhinitis (and allergic conjunctivitis) has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest [NA]
This clinical trial update evaluates whether a tape-based skin prick test provides diagnostically equivalent results to the conventional Ski…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model [Phase 4]
Phase 4 trial update evaluating the efficacy of topical ophthalmic steroids in a modified conjunctival allergen challenge for allergic conju…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model [Phase 4]
Phase 4 clinical trial evaluating the efficacy of topical ophthalmic steroids in a modified conjunctival allergen challenge model for allerg…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Effect of Olopatadine on Allergic Tear Mediators [NA]
A completed clinical trial evaluating the effect of olopatadine on tear mediators in allergic conjunctivitis; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis [Phase 3]
Phase 3 trial for OTX-DP in chronic allergic conjunctivitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis [Phase 3]
Phase 3 trial results for OTX-DP in chronic allergic conjunctivitis were completed and the results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections [Phase 1]
A Phase 1 trial evaluating the safety of Ragweed Mix administered by intralymphatic node injections for allergic conjunctivitis and allergic…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle [Phase 3]
Phase 3 study evaluating onset and duration of action of AC-170 0.24% versus vehicle in allergic conjunctivitis has completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle [Phase 3]
A Phase 3 clinical trial evaluating the onset and duration of action of AC-170 0.24% versus vehicle for allergic conjunctivitis was complete…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) [Phase 3]
A Phase 3 multi-center trial evaluating onset and duration of action of AC-170 0.24% versus vehicle in the conjunctival allergen challenge h…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model [Phase 2]
Phase 2 trial evaluating AC-150 for allergic conjunctivitis completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating AC-170 for allergic conjunctivitis using the conjunctival allergen challenge model has completed and res…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis [Phase 2]
This clinical trial update reports the termination of a Phase 2 study evaluating hydrocortisone ophthalmic ointment 0.5% for allergic conjun…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating olopatadine 0.2% for allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Multi-Center Study Evaluating the Safety of AC-170 0.24% [Phase 3]
A Phase 3 trial evaluating the safety of AC-170 0.24% in atopic disease including allergic conjunctivitis has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Olopatadine Eye Drops and Allergy Skin Testing [NA]
This clinical trial update reports completion and posted results for a study of olopatadine eye drops and allergy skin testing in allergic r…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis [Phase 2]
A Phase 2 efficacy study evaluating three concentrations of SAR 1118 in allergic conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis [Phase 1]
A Phase 1 study evaluated the safety and tolerability of XmAb7195 in healthy adults and adults with allergic rhinitis, allergic conjunctivit…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Mast-Cell Stabilizing Effects of Olopatadine [Phase 4]
Phase 4 clinical trial assessing whether olopatadine stabilizes mast cells in allergic conjunctivitis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects [Phase 3]
This update reports the Phase 3 results of olopatadine hydrochloride ophthalmic solution tested in Chinese subjects for allergic conjunctivi…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
A completed clinical trial evaluated patients with allergic conjunctivitis to determine whether they also have dry eye disease.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase III trial evaluating the safety and efficacy of a 300 IR grass pollen sublingual immunotherapy (SLIT) for grass pollen rhinoconjunctiv…